TrialAmerican journal of nephrology2018

Switching from Epoetin Alfa (Epogen®) to Epoetin Alfa-Epbx (RetacritTM) Using a Specified Dosing Algorithm: A Randomized, Non-Inferiority Study in Adults on Hemodialysis.

Ravi Thadhani et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.